Tamoxifen in breast cancer.
A
A
Anand
D001053:Apolipoproteins; D053399:Apolipoproteins D; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000628:therapy; D002352:Carrier Proteins / Q000032:analysis*; D006023:Glycoproteins; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D026901:Membrane Transport Proteins; D013629:Tamoxifen / Q000627:therapeutic use*
C024328:APOD protein, human; D001053:Apolipoproteins; D053399:Apolipoproteins D; D014408:Biomarkers, Tumor; D002352:Carrier Proteins; D006023:Glycoproteins; D026901:Membrane Transport Proteins; D013629:Tamoxifen; D016899:Interferon-beta